Shiro Suzuki

12PUBLICATIONS
51CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersMedical ethicsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 26, 2025
Efficient expansion of tumor-infiltrating lymphocytes from gynecologic cancer.

Tetsuya Matsukawa, Tsunenori Ouchida, Taeko Hayakawa

|Mar 28, 2025
Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study.

Shin Nishio, Kimio Ushijima, Mitsuya Ishikawa

|Apr 04, 2024
Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancer.

Ryosuke Uekusa, Akira Yokoi, Eri Watanabe

|Feb 01, 2024
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer.

Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa

|Sep 02, 2023
Paclitaxel-carboplatin plus bevacizumab therapy for advanced neuroendocrine carcinoma of the uterine cervix: A retrospective case series.

Saki Kotaka, Eiji Kondo, Yosuke Kawai

|May 12, 2023
Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer.

Saki Kotaka, Eiji Kondo, Yosuke Kawai

Pageof 2

Frequent Collaborators

4 joint publications

Nobuhisa Yoshikawa

4 joint publications

Hiroaki Kajiyama

4 joint publications

Fumitaka Kikkawa

2 joint publications

Kosuke Yoshida